StonvexLoading…
StonvexStonvexStonvexCore line items from AOMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $143.66M | $110.43M | $95.95M | $115.54M |
Operating Income | $44.55M | $32.01M | $34.96M | $-191.29M |
Net Income | $44.02M | $28.75M | $33.71M | $-187.83M |
EPS (Diluted) | $1.80 | $1.17 | $1.35 | $-7.65 |
Total Assets | $2.75B | $2.27B | $2.31B | $2.95B |
Total Liabilities | $2.48B | $2.03B | $2.05B | $2.71B |
Cash & Equivalents | $41.62M | $40.76M | $41.63M | $29.27M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 24.91M | 23.50M | 24.97M | 24.93M |